| Term 
 
        | Endocarditis Risk Factors |  | Definition 
 
        | Valvular Disease, Previous Endocarditis, Congenital Abnormalities, Hypertrophic myopathy, IV Drug Abuse |  | 
        |  | 
        
        | Term 
 
        | Endocarditis Pathogenesis |  | Definition 
 
        | Endothelial surface is damaged Platelets and fibrin deposit on damaged endothelium Bacteremia Organisms colonize surface Vegetation of fibrin, platelets, and bacteria forms Bacterial growth concentrates up to 10^9-10^10 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Protect bacteria from the environment Cause valvular damage Embolization of septic fragments Circulating immune complexes |  | 
        |  | 
        
        | Term 
 
        | Infective Endocarditis caused by |  | Definition 
 
        | S. aureus, CNS - 1st year post prostetic valve surgery, IV drug users Viridans group of strep - more common with mitral valve prolapse following dental Enterococcus - Following genitourinary manipulations |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Fever Dyspnea Nigh sweats New Heart murmur Skin lesions: Conjunctival Petechiae Splinter Hemorrhages Clubbing of fingers Jeneway lesions Roth spots Osler Nodes |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Signs and Symptoms >3 blood cultures at least 1hr apart Echocardiography - transthoracic, transesophageal |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Major: Positive blood cultures >2/2 Positive Echocardiogram Minor: Predisposition to IE Fever Vascular Phenomena Immunologic Phenomena Microbiologic findings |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Vegetations, major emboli or itracardiac abscess 2 major criteria 1 major and 3 minor 5 minor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1 major and 1 minor 3 minor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Firm alternative diagnosis Resolution <4 days after antimicrobials No evidence at surgery |  | 
        |  | 
        
        | Term 
 
        | Usual Pathogens in Adults: Native Valve Non IV drug use |  | Definition 
 
        | S. aureus, MRSA Viridans group strep Enterococcus spp |  | 
        |  | 
        
        | Term 
 
        | Usual Pathogens in Adults: Native Valve IV drug use |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Empiric Antibiotic Therapy: Adult Native Valve Non IVDU |  | Definition 
 
        | Acute: Vancomycin + Ceftriaxone 2g IV daily -> duration 6 weeks if culture negative;  Severe Pen allergy: Vancomycin + Gentamicin -> same duration |  | 
        |  | 
        
        | Term 
 
        | Usual Pathogens in Adults: Prosthetic Valve <8 weeks |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Usual Pathogens in Adults: Prosthetic Valve >8 weeks |  | Definition 
 
        | S. aureus/MRSA CNS Viridans group strep Enteroccocus |  | 
        |  | 
        
        | Term 
 
        | Empiric Antimicrobial Therapy: Prosthetic valve adult (early and late) |  | Definition 
 
        | Vancomycin 15mg/kg iv q8-12h - 6 wks Gentamicin 1mg/kg iv q8h - 2 wks Rifampin 300mg po tid or 600mg bid - 6 wks |  | 
        |  | 
        
        | Term 
 
        | Culture negative endocarditis: potential causes |  | Definition 
 
        | poor collection technique difficult to culture organism previous antimicrobial therapy |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | heart failure unresponsive to therapy perivalvular invasive disease Uncontrolled infection despite maximal antibiotic therapy significant risk of embolic complications prosthetic valve infection |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cardiac: Heart Failure secondary to valvular dysf AV or bundle branch block Increased risk of reinfection   Neurologic: Stroke Syndrome   Systemic Emboli and Slenic Abscess |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Life threatening Certain cardiac conditions predispose pts to infection Bacteremia with known pathgens occurs with invasive procedures Therapy proven effective in animal models |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Prosthetic Cardiac Valves Previous Infective Endocarditis CHD Cardiac transplant recipients who develop valvulopathy |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Only for high risk heart defects Only for dental procedures with manipulation of gingival tissues, or periapical tissue of teeth, or perforation of the oral mucosa Respiratory Tract or Infected skin, skin structures or muscoloskeletal tissues  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Standard: Amoxicillin B-lactam allergy: Clindamycin, Azithromycin, Clarithromycin Give 1hr before dental procedure.  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Standard: Ampicillin  B-lactam allergy: Clindamycin, Cefazolin or ceftriaxone |  | 
        |  |